These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7024644)

  • 1. NIH Consensus Development Conference summary: Adjuvant Chemotherapy of Breast Cancer.
    J Tenn Med Assoc; 1981 Mar; 74(3):190-2. PubMed ID: 7024644
    [No Abstract]   [Full Text] [Related]  

  • 2. NIH consensus-development statement. Adjuvant chemotherapy of breast cancer. The NIH Consensus-Development Panel.
    N Engl J Med; 1980 Oct; 303(14):831-2. PubMed ID: 6997737
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant chemotherapy of breast cancer. National Institutes of Health Consensus Development Conference Summary, Volume 3, Number 3.
    Oncol Nurs Forum; 1981; 8(1):7-9. PubMed ID: 7003562
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant chemotherapy for breast cancer. National Institutes of Health Consensus Development Conference Statement.
    Natl Inst Health Consens Dev Conf Consens Statement; 1985; 5(12):5 p.. PubMed ID: 3908920
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant chemotherapy of breast cancer. Sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1980 Nov; 44(11):721-3. PubMed ID: 7226778
    [No Abstract]   [Full Text] [Related]  

  • 6. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma.
    Lazovich D; Solomon CC; Thomas DB; Moe RE; White E
    Cancer; 1999 Aug; 86(4):628-37. PubMed ID: 10440690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus conference 2000: adjuvant therapy for breast cancer. National Institutes of Health Consensus Development Conference Statement November 1-3, 2000.
    Cancer Control; 2001; 8(1):55. PubMed ID: 11176036
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD; Greenwald P
    Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
    [No Abstract]   [Full Text] [Related]  

  • 11. NCI launches an innovative design for a breast cancer clinical trial.
    Whitworth A
    J Natl Cancer Inst; 2006 Sep; 98(17):1178-9. PubMed ID: 16954467
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical research. No lifeline for proposed breast cancer prevention trial.
    Kaiser J
    Science; 2007 Jun; 316(5832):1679. PubMed ID: 17588904
    [No Abstract]   [Full Text] [Related]  

  • 13. Indications for neoadjuvant chemotherapy for breast cancer.
    Bear HD
    Semin Oncol; 1998 Apr; 25(2 Suppl 3):3-12. PubMed ID: 9566201
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project.
    Newman LA; Mamounas EP
    Surg Clin North Am; 2007 Apr; 87(2):279-305, vii. PubMed ID: 17498527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating promising new treatments for life-threatening disease: implications of the HDC/ABMT experience for treating breast cancer.
    Edwards S
    Find Brief; 2005 Jan; 8(1):1-3. PubMed ID: 15672527
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A United States National Institutes of Health investigation suspended due to risk of breast cancer with use of hormone replacement in menopause].
    Zárate-Treviño A
    Gac Med Mex; 2002; 138(6):595-6. PubMed ID: 12532629
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status of adjuvant endocrine therapy for breast cancer.
    Ingle JN
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4392s-4396s; discussion 4411s-4412s. PubMed ID: 11916230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some thoughts on the future of clinical trials in cancer.
    Wittes RE; Friedman MA; Simon R
    Cancer Treat Rep; 1986 Feb; 70(2):241-50. PubMed ID: 2418968
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant chemotherapy for breast cancer. NIH consensus development conference, September 9-11, 1985.
    Cancer Treat Res; 1992; 60():375-82. PubMed ID: 1355999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.